CEF32, Epstein-Barr Virus latent NA-3C (281-290) is a viral-derived peptide applied in immunological recognition and epitope-mapping research. Its sequence enables focused studies on antigen presentation and peptide-MHC interactions. Investigators leverage it to explore immune signaling associated with latent EBV proteins. The peptide also aids comparative analyses of viral epitope diversity.
CAT No: C14031
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More